Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Rani Therapeutics
RANI
$101M
| $7.63K | ﹤0.01% |
10,036
-210
| -2% | -$186 |
|
4652
Immunic
IMUX
$174M
| $7.59K | ﹤0.01% |
494
+251
| +103% | +$3.1K |
|
4653
Neuronetics
STIM
$223M
| $7.59K | ﹤0.01% |
5,839
-665
| -10% | -$968 |
|
|
DDTD
4654
Innovator Equity Dual Directional 10 Buffer ETF Dec
DDTD
$22.9M
| $7.57K | ﹤0.01% |
+372
| New | +$7.4K |
|
4655
Tilly's
TLYS
$128M
| $7.44K | ﹤0.01% |
1,771
| – | – |
|
|
SIMAU
4656
SIM Acquisition Corp I Unit
SIMAU
| $7.15K | ﹤0.01% |
654
| – | – |
|
|
ZOOZ
4657
ZOOZ Strategy Ltd
ZOOZ
$55.7M
| $7.09K | ﹤0.01% |
+1,280
| New | +$7.54K |
|
4658
Transcontinental Realty Investors
TCI
$338M
| $7.08K | ﹤0.01% |
154
-1
| -0.6% | -$38 |
|
4659
Biodesix
BDSX
$281M
| $7.06K | ﹤0.01% |
+313
| New | +$4.64K |
|
4660
Cardiff Oncology
CRDF
$85.6M
| $7.03K | ﹤0.01% |
5,407
-6,259
| -54% | -$9.94K |
|
4661
TRX Gold Corp
TRX
$370M
| $7.01K | ﹤0.01% |
8,500
+5,800
| +215% | +$6.72K |
|
4662
Silicon Motion
SIMO
$9.22B
| $7K | ﹤0.01% |
+21
| New | +$4.87K |
|
4663
ICL Group
ICL
$7.56B
| $6.96K | ﹤0.01% |
+1,397
| New | +$7.94K |
|
4664
Elicio Therapeutics
ELTX
$61.8M
| $6.94K | ﹤0.01% |
+1,776
| New | +$17.8K |
|
4665
FibroBiologics
FBLG
$11.4M
| $6.86K | ﹤0.01% |
+7,243
| New | +$8.41K |
|
|
CNTB
4666
Connect Biopharma Holdings
CNTB
$120M
| $6.85K | ﹤0.01% |
+2,879
| New | +$6.98K |
|
|
FNUC
4667
Frontier Nuclear and Minerals Inc
FNUC
$53.5M
| $6.78K | ﹤0.01% |
4,428
+3,987
| +904% | +$8.72K |
|
|
IVA
4668
Inventiva
IVA
$1.1B
| $6.73K | ﹤0.01% |
+1,781
| New | +$8.56K |
|
4669
Innovator US Equity Buffer ETF March
BMAR
$207M
| $6.51K | ﹤0.01% |
+113
| New | +$6.37K |
|
4670
Lakeland Industries
LAKE
$114M
| $6.29K | ﹤0.01% |
588
-1,395
| -70% | -$14.1K |
|
4671
Compugen
CGEN
$243M
| $6.22K | ﹤0.01% |
+2,906
| New | +$7.28K |
|
4672
KE Holdings
BEKE
$19B
| $6.07K | ﹤0.01% |
418
-2,946
| -88% | -$48.5K |
|
4673
Eastern Company
EML
$157M
| $6.04K | ﹤0.01% |
217
-1,063
| -83% | -$23.3K |
|
4674
Innovator US Equity Power Buffer ETF November
PNOV
$889M
| $6.03K | ﹤0.01% |
136
-1,533
| -92% | -$66.6K |
|
|
DQ
4675
Daqo New Energy
DQ
$844M
| $6.03K | ﹤0.01% |
450
-5,906
| -93% | -$107K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.